Marshall Islands Healthcare Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Islands Healthcare Brief.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 16, 2026

Mar. 16, 2026

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

GlobeNewswire

Mar. 16, 2026

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…

GlobeNewswire

Mar. 16, 2026

Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

GlobeNewswire

Mar. 16, 2026

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

GlobeNewswire

Mar. 16, 2026

Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

GlobeNewswire

Mar. 16, 2026

Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

GlobeNewswire

Mar. 16, 2026

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

GlobeNewswire

Mar. 16, 2026

Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments

GlobeNewswire

Mar. 16, 2026

vTv Therapeutics to Participate in the 38th Annual ROTH Conference

GlobeNewswire

Mar. 16, 2026

4DMT to Participate in Upcoming Investor Meetings

GlobeNewswire

Mar. 16, 2026

George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement

GlobeNewswire

Mar. 16, 2026

Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

GlobeNewswire

Mar. 16, 2026

Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth

GlobeNewswire

Mar. 16, 2026

Extendicare Announces March 2026 Dividend of C$0.0441 per Share

GlobeNewswire

Mar. 16, 2026

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire

Mar. 16, 2026

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

GlobeNewswire

Mar. 16, 2026

New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026

GlobeNewswire

Mar. 16, 2026

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

GlobeNewswire

Mar. 16, 2026

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

GlobeNewswire

Mar. 16, 2026

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

GlobeNewswire